New Current Report Filed with the SEC Disclosing Receipt of a Notice of Delisting, the Failure to Satisfy a Continued Listing Rule or Standard or the Transfer of a Listing: 8-K – PERNIX THERAPEUTICS HOLDINGS, INC. (0001024126) (Filer)





A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing receipt of a notice of delisting, the failure to satisfy a continued listing rule or standard or the transfer of a listing. Details of the current report are:

8-K – PERNIX THERAPEUTICS HOLDINGS, INC. (0001024126) (Filer)
Filed: 2016-06-22 AccNo: 0001654954-16-000534 Size: 58 KB

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 8.01: Other Events

Item 9.01: Financial Statements and Exhibits
Filing Date: 2016-06-22T10:30:18-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1024126/000165495416000534/0001654954-16-000534-index.htm